Bibliographic information

GuidelineSelected practice recommendations for contraceptive use, 4th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization

Recommendation

New

Misoprostol is not recommended for routine use before intrauterine device (IUD) placement. Misoprostol might be helpful in select circumstances (e.g. in clients with a recent failed placement).

Recommended against

Conditional

Notes and Remarks

Barriers to IUD use include client concerns about anticipated pain with placement and provider concerns about ease of placement, especially among nulliparous clients. Therefore, before an IUD is placed, all clients should be counselled on the possibility of pain during placement, the risks and benefits of an IUD, and alternatives to it. They should also be told about the different options for pain management. A person-centred plan for IUD placement and pain management should be made and it should be based on client preferences. Misoprostol should not be used for routine IUD placements. Misoprostol might increase client pain, preplacement abdominal cramping and/or preplacement diarrhoea.‒ In women with a recent failed IUD placement, preliminary treatment with 400 μg vaginal misoprostol (200 μg administered 10 hours before and 200 μg administered 4 hours before returning to the clinic) may increase the chances of a successful placement.